Home › Open-Angle Glaucoma
Pag-aaral pangklinika para sa Open-Angle Glaucoma na nagre-recruit sa U.S.
34 pag-aaral para sa Open-Angle Glaucoma ang nagre-recruit ng mga kalahok sa mga site sa buong Estados Unidos.
Mga lungsod na may pinakamaraming pag-aaral
- Kenosha, WI5 pag-aaral
- Philadelphia, PA5 pag-aaral
- Boston, MA3 pag-aaral
- Austin, TX3 pag-aaral
- El Paso, TX3 pag-aaral
- Dallas, TX3 pag-aaral
- Oklahoma City, OK3 pag-aaral
- Roswell, GA3 pag-aaral
- Houston, TX3 pag-aaral
- Santa Rosa, CA3 pag-aaral
Ayos sa estado
- Arizona4 pag-aaral
- California9 pag-aaral
- Colorado4 pag-aaral
- Florida6 pag-aaral
- Georgia3 pag-aaral
- Maryland3 pag-aaral
- Massachusetts4 pag-aaral
- Minnesota3 pag-aaral
- Ohio3 pag-aaral
- Oklahoma3 pag-aaral
- Pennsylvania6 pag-aaral
- Texas9 pag-aaral
- Wisconsin5 pag-aaral
Mga pag-aaral na kamakailan lamang in-update
Opisyal na teksto ng pag-aaral (English)
Adaptive Optics OCT Evaluation of Rhopressa's Effects on the Retinal Ganglion Cells in Glaucoma Patients
Nagre-recruitPhase 4
Edad 18 pataas · Lahat ng kasarian · Na-update Set 29, 2026 · NCT07847073A Study to Assess Adverse Events and Effectiveness of Gel Stent (XEN63) Implantation Using Ab Interno and Ab Externo Approaches in Adult Participants With Glaucoma
Nagre-recruitPhase 3
Edad 45 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT06822738REGN22530 for Adults With Primary Open Angle Glaucoma or Ocular Hypertension
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07675824A Study to Evaluate Efficacy and Safety of YSBP Compared to Lumigan in Patients With Glaucoma or Ocular Hypertension
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 23, 2026 · NCT07661329Hydrus® Microstent New Enrollment Post-Approval Study
Nagre-recruit
Edad 45 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT04553523Phase 2 Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 17, 2026 · NCT07075718iDose TR Administration in an Office-Based Surgery Setting
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Set 14, 2026 · NCT07816692A Study to Assess Brillouin Hydration Mapping for the Evaluation of Ocular Tissues and Diseases
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 20 hanggang 79 · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT07780890Caffeine Consumption in Glaucoma Patients and Healthy Subjects
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 hanggang 90 · Lahat ng kasarian · Na-update Ago 20, 2026 · NCT03675412Travoprost Intraocular Implant + iStent Infinite
Nagre-recruitPhase 4
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 2, 2026 · NCT06066645Evaluating ER-100 for Safety in People With Glaucoma or Non-Arteritic Anterior Ischemic Optic Neuropathy (Optic Nerve Conditions)
Nagre-recruitPhase 1
Edad 40 hanggang 85 · Lahat ng kasarian · Na-update May 19, 2026 · NCT07290244Adaptive Optics Retinal Imaging
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
Edad 21 pataas · Lahat ng kasarian · Na-update May 8, 2026 · NCT05370287Direct vs Standard SLT for Glaucoma: A Noninferiority Trial
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update May 6, 2026 · NCT0740815424-hour Effect of Rocklatan Compared With Latanoprost in Open Angle Glaucoma and Ocular Hypertension Patients
Nagre-recruitPhase 4
Edad 18 pataas · Lahat ng kasarian · Na-update May 1, 2026 · NCT07325240DSLT for Reducing Medication in Glaucoma
Nagre-recruitObservasyonal na pag-aaral
Lahat ng edad · Lahat ng kasarian · Na-update Abr 20, 2026 · NCT07390890Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Mar 30, 2026 · NCT07495852A Trial of Hydrus Microstent Versus Goniotomy
Nagre-recruit
Edad 40 hanggang 85 · Lahat ng kasarian · Na-update Mar 30, 2026 · NCT06289491Biomarkers of Ocular Surface Damage in the Setting of Topical Ocular Hypotensive Medication Use
Nagre-recruitPhase 4
Edad 18 pataas · Lahat ng kasarian · Na-update Mar 5, 2026 · NCT07217678Observational Trial of the Updated Inserter for the Travoprost Intracameral Implant 75mcg
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Peb 27, 2026 · NCT07400926Safety and Efficacy of iDose® TR With Cataract Surgery vs. Cataract Surgery Alone
Nagre-recruitPhase 4
Edad 45 pataas · Lahat ng kasarian · Na-update Ene 21, 2026 · NCT06848946Safety and Effectiveness of the VisiPlate Aqueous Shunt in Patients With Refractory Open-Angle Glaucoma
Nagre-recruit
Edad 45 pataas · Lahat ng kasarian · Na-update Dis 15, 2025 · NCT07220876Standalone iStent Infinite and iDose TR for Management of Moderate to Severe Open Angle Glaucoma
Nagre-recruitPhase 4
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 14, 2025 · NCT07228221Electrical Stimulation for Vision Neuroenhancement in Glaucoma
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 4, 2025 · NCT06685211Diagnostic Innovations in Glaucoma Study
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 24, 2025 · NCT00221897Glaucoma, Visual Field Loss, and Their Association With Life Space in Older Adults
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 hanggang 100 · Lahat ng kasarian · Na-update Set 12, 2025 · NCT04396002Mula sa ClinicalTrials.gov, na-kuha noong Set 30, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.